Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$619 Buy
39
+5
+15% +$77 ﹤0.01% 693
2026
Q1
$459 Hold
34
﹤0.01% 738
2025
Q4
$423 Buy
+34
New +$367 ﹤0.01% 745
2024
Q4
Sell
-37
Closed -$430 427
2024
Q3
$430 Hold
37
﹤0.01% 388
2024
Q2
$393 Sell
37
-64
-63% -$707 ﹤0.01% 336
2024
Q1
$1.21K Hold
101
﹤0.01% 326
2023
Q4
$1.09K Hold
101
﹤0.01% 296
2023
Q3
$996 Buy
101
+37
+58% +$385 ﹤0.01% 307
2023
Q2
$639 Buy
+64
New +$611 ﹤0.01% 316

Other funds holding VTRS

Trust Company's VTRS Position: Q2 2026 in Review

Trust Company increased its Viatris (VTRS) stake by 15% in Q2 2026, buying an estimated $77 and bringing the position to 39 shares worth $619. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Trust Company first reported a position in VTRS in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.21K in Q1 2024. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Trust Company held 39 shares of Viatris worth $619 as of Q2 2026.
  • Trust Company bought 5 Viatris shares in Q2 2026, an estimated $77.
  • Viatris made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #693 holding.
  • Trust Company first reported a position in Viatris in Q2 2023 and has held it in 9 quarters since.
  • Trust Company's Viatris position peaked at $1.21K in Q1 2024.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.